Zabofloxacin is primarily used as an antibiotic in the treatment of bacterial infections. It is effective against a wide range of Gram-positive and Gram-negative bacteria, making it valuable in combating respiratory tract infections, such as pneumonia and bronchitis. Its mechanism of action involves inhibiting bacterial DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication and repair. This makes it particularly useful in cases where other antibiotics have failed due to resistance. Zabofloxacin is also being explored for its potential in treating complicated skin and soft tissue infections. Its broad-spectrum activity and ability to penetrate tissues effectively contribute to its therapeutic efficacy.